Rhythm Pharma

Recording available now: Rhythm-sponsored Satellite Symposium at ECO 2024

Precision medicine in treating leptin melanocortin-4 receptor (MC4R) pathway diseases: addressing hyperphagia and early-onset severe obesity

KEY TOPICS:

Genetic impairments in the MC4R pathway and their role in hyperphagia and early-onset, severe obesity
Overview of MC4R pathway diseases, focusing on POMC, PCSK1 and LEPR deficiency
The role of precision medicine in the management of monogenic MC4R pathway disease
Overview of MC4R pathway diseases, focusing on Bardet-Biedl Syndrome (BBS)
The role of precision medicine in the management of BBS

Precision medicine in treating leptin melanocortin-4 receptor (MC4R) pathway diseases

Dr Metin Cetiner, MD, PhD

Reproducir vídeo

Rhythm Pharmaceuticals utiliza la herramienta de Autenticación de Profesionales Sanitarios de IQVIA para comprobar su elegibilidad para acceder a este contenido audiovisual. Si ya dispone de una cuenta de IQVIA que utiliza con otros profesionales sanitarios, haga clic en 'Iniciar sesión'; de lo contrario, haga clic en 'Registrarse'.

Iniciar sesión Registrarse

Precision medicine in treating leptin melanocortin-4 receptor (MC4R) pathway diseases: Addressing hyperphagia and early-onset, severe obesity

Prof Pietro Maffei

Reproducir vídeo

Rhythm Pharmaceuticals utiliza la herramienta de Autenticación de Profesionales Sanitarios de IQVIA para comprobar su elegibilidad para acceder a este contenido audiovisual. Si ya dispone de una cuenta de IQVIA que utiliza con otros profesionales sanitarios, haga clic en 'Iniciar sesión'; de lo contrario, haga clic en 'Registrarse'.

Iniciar sesión Registrarse

Speakers:

Dr Danilo Fintini

(Italy)

Prof Giovanni Ceccarini

(Italy)

If you are interested in hearing more about future Rhythm sponsored events, click here to register your interest.

This meeting was organised and funded by Rhythm Pharmaceuticals and is intended for healthcare professionals only.